Lymphoseek© Clinical Studies
Lymphoseek has been studied extensively, including in three comprehensive Phase III protocols in breast cancer, melanoma and head and neck squamous cell carcinoma.. These Phase III results have been presented at the annual scientific conferences of many of the world’s leading oncology associations, including the American Society of Clinical Oncology (ASCO) and the Society for Nuclear Medicine and Molecular Imaging and published in the journal Annals of Surgical Oncology. Earlier-phase studies conducted at University of California at San Diego (UCSD) through grants from the Susan G. Komen Breast Cancer Research Foundation, have been published in leading cancer journals including Journal of Nuclear Medicine and Annals of Surgical Oncology. Clinical research continues with investigator initiated clinical trials in other cancer types.